October 31, 2023
VAUGHAN, Ontario – Bausch + Lomb Corporation has launched the enVista Aspire monofocal and toric intraocular lenses (IOLs) with Intermediate Optimized (IO) optics in the United States. enVista Aspire combines novel optics, which are designed for a broader depth of focus, with the proven benefits of the enVista platform family of IOLs.
Unlike conventional spherical monofocal IOLs and lower-order aspheric IOLs, enVista Aspire optics allow for a range of vision beyond one focal point. Like enVista MX60E, enVista Aspire offers a glistening-free optic material and controlled, efficient unfolding through Bausch + Lomb’s proprietary StableFlex Technology, which aids optic recovery.
“enVista IOLs are well known by cataract surgeons who have chosen the platform for millions of patients worldwide,” said Luc Bonnefoy, president, Surgical, Bausch + Lomb. “The added feature of broader depth of focus makes enVista Aspire a compelling new option for the many patients who use digital devices on a daily basis.”
For patients with astigmatism, enVista Aspire Toric IOLs provide a proven option for treatment of their astigmatism during cataract surgery. Featuring a low cylinder design, enVista is the only toric IOL platform available to treat less than one diopter of astigmatism at the corneal plane. The unique AccuSet haptic design allows for exceptional rotational stability, an important attribute for toric lenses.
